Want to see REPL full AI Analyst Report?
ETFs with Replimune Group (REPL) Exposure
The following ETFs maintain exposure to Replimune Group (REPL). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
52 ETFs Hold Replimune Group (REPL)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in REPL |
|---|---|---|---|---|---|---|
| LFSC | F/M Emerald Life Sciences Innovation ETF | $125.43M | 0.54% | 8.66% | $10.86M | 0.66% |
| SPIT | F/m Emerald Special Situations ETF | $33.24M | 0.89% | 2.55% | $848.96K | 0.05% |
| DWAS | Invesco DWA SmallCap Momentum ETF | $397.64M | 0.60% | 1.59% | $6.17M | 0.37% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 1.54% | $529.94K | 0.03% |
| CHNA | ― | ― | ― | 1.13% | $42.18K | <0.01% |
| MEDX | Horizon Kinetics Medical ETF | $17.76M | 0.85% | 1.11% | $197.79K | 0.01% |
| CANC | Tema Oncology ETF | $216.18M | 0.75% | 0.91% | $1.97M | 0.12% |
| TDNA | T. Rowe Price Biotech ETF | $11.32M | 0.55% | 0.84% | $95.45K | <0.01% |
| NIFE | ― | ― | ― | 0.53% | $11.99K | <0.01% |
| SGRW | Harbor Active Small Cap Growth ETF | $28.11M | 0.80% | 0.48% | $134.18K | <0.01% |
| XBI | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | 0.42% | $45.21M | 2.74% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.34% | $4.26M | 0.26% |
| OPTZ | Optimize Strategy Index ETF | $264.57M | 0.25% | 0.21% | $556.93K | 0.03% |
| VFMO | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | 0.12% | $2.26M | 0.14% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.11% | $127.57K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.10% | $12.03M | 0.72% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.10% | $1.39M | 0.08% |
| PRFZ | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | 0.10% | $2.69M | 0.16% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | 0.09% | $13.10M | 0.79% |
| PWS | Pacer WealthShield ETF | $14.55M | 0.60% | 0.08% | $12.36K | <0.01% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | 0.07% | $987.37K | 0.08% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | 0.06% | $646.29K | 0.04% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.05% | $2.32M | 0.14% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.05% | $35.97M | 2.18% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.05% | $148.96K | <0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.05% | $679.55K | 0.04% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | 0.04% | $2,643.28 | <0.01% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.04% | $79.14K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | 0.04% | $486.92 | <0.01% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.04% | $5,070.92 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.04% | $6.20M | 0.49% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | 0.03% | $7.38M | 0.45% |
| FESM | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | 0.03% | $2.03M | 0.12% |
| VFLQ | ― | ― | ― | 0.02% | $7,416 | <0.01% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | 0.01% | $11.98M | 0.95% |
| DFMC | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | 0.01% | $957.39K | 0.09% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | 0.01% | $2.29M | 0.18% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $1,704.22 | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $476.97K | 0.03% |
| CAUS | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | <0.01% | $20.58K | <0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $1.97M | 0.12% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $406.98K | 0.02% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | <0.01% | $1.47M | 0.09% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $737.28K | 0.04% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $94.56K | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $32.01M | 2.55% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $433.17K | 0.03% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $19.88K | <0.01% |
| AVUS | Avantis U.S. Equity ETF | $14.88B | 0.15% | <0.01% | $59.82K | <0.01% |
| DFUS | Dimensional U.S. Equity ETF | $21.88B | 0.09% | <0.01% | $76.83K | <0.01% |
| DFAU | Dimensional US Core Equity Market ETF | $13.11B | 0.12% | <0.01% | $17.37K | <0.01% |
| DDUM | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | <0.01% | $139.12 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in REPL |
|---|---|---|---|---|---|---|
| LFSC | 8.66% | F/M Emerald Life Sciences Innovation ETF | $125.43M | 0.54% | $10.86M | 0.66% |
| SPIT | 2.55% | F/m Emerald Special Situations ETF | $33.24M | 0.89% | $848.96K | 0.05% |
| DWAS | 1.59% | Invesco DWA SmallCap Momentum ETF | $397.64M | 0.60% | $6.17M | 0.37% |
| BBC | 1.54% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $529.94K | 0.03% |
| CHNA | 1.13% | ― | ― | ― | $42.18K | <0.01% |
| MEDX | 1.11% | Horizon Kinetics Medical ETF | $17.76M | 0.85% | $197.79K | 0.01% |
| CANC | 0.91% | Tema Oncology ETF | $216.18M | 0.75% | $1.97M | 0.12% |
| TDNA | 0.84% | T. Rowe Price Biotech ETF | $11.32M | 0.55% | $95.45K | <0.01% |
| NIFE | 0.53% | ― | ― | ― | $11.99K | <0.01% |
| SGRW | 0.48% | Harbor Active Small Cap Growth ETF | $28.11M | 0.80% | $134.18K | <0.01% |
| XBI | 0.42% | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | $45.21M | 2.74% |
| IWC | 0.34% | iShares Micro-Cap ETF | $1.26B | 0.60% | $4.26M | 0.26% |
| OPTZ | 0.21% | Optimize Strategy Index ETF | $264.57M | 0.25% | $556.93K | 0.03% |
| VFMO | 0.12% | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | $2.26M | 0.14% |
| IBBQ | 0.11% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $127.57K | <0.01% |
| IBB | 0.10% | iShares Biotechnology ETF | $11.52B | 0.44% | $12.03M | 0.72% |
| OM3E | 0.10% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $1.39M | 0.08% |
| PRFZ | 0.10% | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | $2.69M | 0.16% |
| IWN | 0.09% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $13.10M | 0.79% |
| PWS | 0.08% | Pacer WealthShield ETF | $14.55M | 0.60% | $12.36K | <0.01% |
| VTWV | 0.07% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $987.37K | 0.08% |
| GSSC | 0.06% | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | $646.29K | 0.04% |
| R2EH | 0.05% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $2.32M | 0.14% |
| IWM | 0.05% | iShares Russell 2000 ETF | $76.76B | 0.19% | $35.97M | 2.18% |
| RTYS | 0.05% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $148.96K | <0.01% |
| RSSL | 0.05% | Global X Russell 2000 ETF | $1.47B | 0.08% | $679.55K | 0.04% |
| RESM | 0.04% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $2,643.28 | <0.01% |
| ITWO | 0.04% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $79.14K | <0.01% |
| RB | 0.04% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $486.92 | <0.01% |
| VRSD | 0.04% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $5,070.92 | <0.01% |
| VTWO | 0.04% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $6.20M | 0.49% |
| SCHA | 0.03% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $7.38M | 0.45% |
| FESM | 0.03% | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | $2.03M | 0.12% |
| VFLQ | 0.02% | ― | ― | ― | $7,416 | <0.01% |
| VXF | 0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $11.98M | 0.95% |
| DFMC | 0.01% | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | $957.39K | 0.09% |
| VHT | 0.01% | Vanguard Health Care ETF | $20.70B | 0.09% | $2.29M | 0.18% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $1,704.22 | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $476.97K | 0.03% |
| CAUS | <0.01% | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | $20.58K | <0.01% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $1.97M | 0.12% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $406.98K | 0.02% |
| DFAC | <0.01% | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | $1.47M | 0.09% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $737.28K | 0.04% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $94.56K | <0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $32.01M | 2.55% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $433.17K | 0.03% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $19.88K | <0.01% |
| AVUS | <0.01% | Avantis U.S. Equity ETF | $14.88B | 0.15% | $59.82K | <0.01% |
| DFUS | <0.01% | Dimensional U.S. Equity ETF | $21.88B | 0.09% | $76.83K | <0.01% |
| DFAU | <0.01% | Dimensional US Core Equity Market ETF | $13.11B | 0.12% | $17.37K | <0.01% |
| DDUM | <0.01% | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | $139.12 | <0.01% |
Popular ETF Comparisons
REPL ETF Exposure FAQ
What ETFs hold Replimune Group stock?
Replimune Group (REPL) is currently held by 52 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to REPL include F/m (LFSC), Invesco (DWAS) and Tema (CANC).
Which ETF has the largest exposure to REPL?
The ETF with the largest exposure to REPL is F/m (LFSC), with approximately $10.86M in market value exposure.
How much REPL stock is held by ETFs?
ETFs currently hold approximately $20.87M worth of Replimune Group (REPL) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.